Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;

Secukinumab as biological treatment for psoriatic arthritis in real clinical practice José A. Pinto Tasende; Francisco J. Maceiras Pan; José A. Mosquera Martínez; Luis Fernández Dominguez; Blanca Correa Rey; Carlos García Porrúa;

Increased risk of stroke among patients with ankylosing spondylitis: A systematic review and meta-analysis Akshaya Srikanth Bhagavathula; Barry L. Bentley; Benjamin Woolf; Thusharika D. Dissanayaka; Jamal Rahmani;